A sandwich enzyme immunoassay for human muscle-specific beta-enolase and its application for the determination of skeletal muscle injury

Antibodies against human muscle enolase recognize a 45-kDa bacterial cell wall outer membrane enolase-like protein

Enolase, is a glycolytic enzyme ubiquitous in higher organisms, where it forms tissue specific dimers of isoforms, also found in the cytoplasm of fermentative bacteria. The aim of this work was to identify enolase-like proteins in the cell wall of some Gram-negative bacteria using antibodies against human beta-enolase, an isoenzyme specific to skeletal and heart muscles. Cell wall outer membrane protein (OMP) preparations were obtained from 9 strains of Enterobacteriaceae and one of Pseudomonas aeruginosa. Specific enzymatic enolase activity was detected in the supernatant fractions of cytosolic and inner membrane material, but not in purified OMP preparations. Rabbit polyclonal antibodies specific against human beta-enolase were prepared and purified using immobilized human beta-enolase in affinity chromatography. In SDS-polyacrylamide gel electrophoresis and immunoblotting assay of purified OMP preparations, rabbit anti-enolase antibody interacted specifically with a few OMPs, of which a 45-kDa band also interacted with human sera of patients presenting Buerger disease and atherosclerosis. The most distinct interaction of human sera was observed with a 45-kDa OMP of Klebsiella pneumoniae. This protein was further isolated from K. pneumoniae cell mass in two ways, namely preparative SDS-polyacrylamide gel electrophoresis and specific affinity chromatography using immobilized affinity-purified rabbit antibody raised against human beta-enolase. The data obtained from tandem mass spectrometry tryptic peptide analysis and sequence comparison of human and bacterial enolases using protein databases, could reveal the similarity in the epitopes between membrane enolase-like protein from Klebsiella and human beta-enolase. The results show that the protein present in all studied strains has a common epitope on human beta-enolase. These data raise the question whether such a bacterial protein might be a marker for detecting and monitoring damage to skeletal and heart muscles.

Evaluation of human beta-enolase as a serum marker for exercise-induced muscle damage

OBJECTIVE

To evaluate whether the serum beta-enolase level is a useful indicator of exercise-induced muscle damage in athletes.

DESIGN

Blood samples were taken from 49 adult amateur marathon runners before and immediately after a marathon race, and the serum levels of beta-enolase and creatine phosphokinase were measured.

SETTING

The Aoshima Taiheiyo Marathon 2000, Miyazaki, Japan, on a cloudy day in December with an ambient temperature of 18 degrees C.

SUBJECTS

Forty-nine adult amateur marathon runners (42 men and 7 women) who regularly participated in runs.

INTERVENTION

The intervention was a marathon run.

MAIN OUTCOME MEASURES

Serum beta-enolase was measured using a sensitive sandwich enzyme-linked immunosorbent assay. Serum creatine phosphokinase was measured using a standard procedure.

RESULTS

The mean beta-enolase concentration was 9.45 +/- 3.11 ng/mL before the race. It increased to 22.11 +/- 8.80 ng/mL after the race, representing a proportional increase of 1.57 +/- 1.46. The serum concentration of beta-enolase after the race was significantly higher than that before the race (P < 0.0001). Moreover, the serum beta-enolase level increased as much as the creatine phosphokinase level after the race, and strongly correlated with creatine phosphokinase (r = 0.828, P < 0.0001). The proportional increase of beta-enolase also correlated with that of creatine phosphokinase (r = 0.441, P < 0.005).

CONCLUSIONS

Our data suggest that the absolute values of the serum beta-enolase are more appropriate to relate to muscle damage.

Determination of pancreas injury from bloodstains using human pancreatic elastase III as a marker

A sensitive sandwich enzyme immunoassay for human pancreatic elastase III as a method to identify pancreas injuries from blood or bloodstains was evaluated. The serum levels of human elastase III from healthy adults (n=24) were estimated to be 1.15 +/- 0.6 (+/- SD) ng/ml. The recovery rates of elastase III added to normal human serum were estimated to be 96.3%. Elastase III levels in contents of various digestive organs were assayed and found to be high in the contents of the large intestine. For detection of human elastase III on weapons, samples were prepared from disposable scalpels that had been used to cut skin and skeletal muscle, and then to cut various organs. The mean ratio of elastase III to total protein (ng elastase III/mg protein) on scalpels that had been cut the pancreas (n=11) was 4956+/-3067 (+/- SD), whereas the ratios from other organs were much lower except, in case of several digestive organs. The higher elastase III levels detected in these digestive organs seemed to stem from the amount of intestinal contents adhering to the scalpels. These results suggest that determination of pancreatic elastase III in blood or bloodstains using a sandwich enzyme immunoassay is a very useful and effective tool for identification of pancreas injury in forensic practice.

A sandwich enzyme immunoassay for human pancreatic elastase III

To develop a method for the determination of pancreas injuries using a pancreas-specific antigen as a marker, human elastase III was purified from the pancreas by chromatographic methods. A rabbit anti-human elastase III antibody was prepared, and this antibody was confirmed using immunoblotting to react only with elastase III among proteins from the pancreas. A sensitive sandwich enzyme immunoassay for human elastase III was developed. The detection limit for human elastase III was 0.3 pg (10 amol) per assay. Proteins extracted from the pancreas showed the strongest response, whereas reactions of the other organs were less than the detection limit. These results suggest that a sandwich enzyme immunoassay for human elastase III is useful for the determination of pancreas injury.

A novel method of species identification using human muscle-specific beta-enolase

A novel method of species identification using a sensitive sandwich enzyme immunoassay for human muscle-specific beta-enolase was used to analyze bloodstains and skeletal muscle. Human beta-enolase is detectable in human blood at dilutions up to 3 x 10(3) and human muscle extract (0.1 g/ml) at dilutions up to 5 x 10(6) using a sandwich enzyme immunoassay. The cross-reactivities of both blood and skeletal muscle extracts from other species were 0.01 or less. When human skeletal muscle extract was added in a final concentration of 10 mg/ml, the ratio of beta-enolase to total protein in bloodstains was approximately 1000, whereas the addition of skeletal muscle extract of other species resulted in a ratio of less than 10. Application of this method in a practical case proved that human muscle-specific beta-enolase as a marker for species identification is very effective in forensic practice.